T-Knife Therapeutics

Biotechnology

T-Knife Therapeutics is a private biotechnology company. It has raised $110 million across 1 recorded round; the latest was an $110 million Series B in Aug 2021.

PMV mark · valuation
—
Oct 2026
Priced at
—
Total raised
$110.0M
Last round
Later Stage VC (Series B)
Aug 2021

T-Knife Therapeutics key facts

as of Oct 2026
  • It has raised $110.0M across 1 recorded rounds; the latest was Later Stage VC (Series B) ($110.0M) in Aug 2021.
  • 2 institutional filers report fund marks on T-Knife Therapeutics across 18 filings.
PrivateMarketView mark
LOW confidence
—

set by institutional fund marksas of Oct 2026question about this number?
Free account
More of T-Knife Therapeutics with a free account
  • ·Watch T-Knife Therapeutics: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

Institutional fund marks on T-Knife Therapeutics

2 filers · latest Jul 2026

2 SEC-registered funds reported 18 fair-value marks on T-Knife Therapeutics between Apr 2025 and Jul 2026. Filer-level marks and implied $/share are available to Pro members.

Unlock 18 fund marks

Membership and data by Private Market View

Every name the funds mark, next to where it trades →

T-Knife Therapeutics funding rounds

1 rounds
Aug 2021Later Stage VC (Series B)$110.0M▮

Recent activity

In the last 90 days, T-Knife Therapeutics's record added 3 institutional fund marks (latest period Jul 2026).

How much has T-Knife Therapeutics raised?

T-Knife Therapeutics has raised $110 million across 1 recorded round since 2021. The largest was an $110 million Series B in Aug 2021.

Institutional holders and vehicles

2 SEC-registered funds reported 18 fair-value marks on T-Knife Therapeutics between Apr 2025 and Jul 2026, in their N-PORT filings. Filer-level marks and implied per-share values are available to Pro members.

About T-Knife Therapeutics

Industry
Biotechnology

Is this your company? Sign in with your work email to keep it current, or tell us what's wrong.